Singapore markets open in 3 hours 20 minutes
Straits Times Index
3,293.13 +20.41 (+0.62%) S&P 500
5,071.63 +1.08 (+0.02%) Dow
38,460.92 -42.77 (-0.11%) Nasdaq
15,712.75 +16.11 (+0.10%) Bitcoin USD
64,319.45 -2,031.33 (-3.06%) CMC Crypto 200
1,385.35 -38.75 (-2.72%)
Arcturus Therapeutics Holdings Inc. (ARCT)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 27.93 |
| Open | 28.20 |
| Bid | 26.93 x 100 |
| Ask | 27.03 x 100 |
| Day's range | 26.58 - 28.33 |
| 52-week range | 17.52 - 43.81 |
| Volume | |
| Avg. volume | 484,137 |
| Market cap | 726.172M |
| Beta (5Y monthly) | 2.60 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.12 |
| Earnings date | 07 May 2024 - 13 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 67.63 |
GuruFocus.comArcturus Therapeutics Holdings Inc (ARCT) Insider Sells Shares
Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT), a biotechnology company focused on the discovery, development, and commercialization of RNA therapeutics for rare diseases and vaccines, has reported an insider transaction.
GuruFocus.comArcturus Therapeutics Holdings Inc's Chief Scientific Officer & COO Pad Chivukula Sells ...
Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT), a biotechnology company focused on the discovery, development, and commercialization of RNA therapeutics for rare diseases and vaccines, has reported an insider sale according to a recent SEC filing.
Simply Wall St.Arcturus Therapeutics Holdings Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
Arcturus Therapeutics Holdings ( NASDAQ:ARCT ) Full Year 2023 Results Key Financial Results Revenue: US$166.8m (down...
© 2024 Yahoo. All rights reserved.